Clinical Trial Update: A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study evaluating the safety, tolerability, and pharmacokinetics of SV001 in Chinese healthy adult volunteers, with Idiopathic Pulmonary Fibrosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• SV001

Snippet

Sponsor: Shanghai Synvida Biotechnology Co.,Ltd. | Conditions: Idiopathic Pulmonary Fibrosis | EARLY_Phase 1 | Status: RECRUITING